Who
Kenneth A. Stauderman
Chief Scientific Officer
Company insider
Files Form 4 as: Chief Scientific Officer, CalciMedica.
In numbers
- Trades disclosed
- 25
- Buys
- 2
- Sells
- 1
- Bought
- $5,810
- Sold
- $3,650
- Companies
- 1
- Companies where not an officer
- 0
- First trade
- 20 Mar 2023
- Last trade
- 24 Sep 2026
- Last filed
- 28 Sep 2026
Companies traded
Activity over time
1 Jun 2025 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 24 Sep 2026filed 28 Sep 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 24 Sep 2026filed 28 Sep 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —180,000 at $0.00 | filing |
| 28 Jul 2025filed 29 Jul 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $3,9601,000 at $3.96 | filing |
| 25 Jul 2025filed 29 Jul 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Sold | $3,6501,000 at $3.65 | filing |
| 1 Jul 2025filed 2 Jul 2025 | CALC CalciMedicaBiotechnology | SEC FORM 4 Bought | $1,8501,000 at $1.85 | filing |
| 24 Jun 2025filed 26 Jun 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —47,125 at $0.00 | filing |
| 23 Apr 2025filed 25 Apr 2025 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —125,000 at $0.00 | filing |
| 5 Apr 2025filed 7 Apr 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,124 at $0.00 | filing |
| 5 Apr 2025filed 7 Apr 2026 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —65,124 at $0.00 | filing |
| 27 Aug 2024filed 28 Aug 2024 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 28 Mar 2024filed 22 Apr 2024 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —62,500 at $0.00 | filing |
| 8 May 2023filed 10 May 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —68,988 at $0.00 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —22,777 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —8,640 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —21,647 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,264 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —13,147 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —7,264 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —5,472 | filing |
| 20 Mar 2023filed 22 Mar 2023 | CALC CalciMedicaoption or derivative · Biotechnology | SEC FORM 4 Code A | —661 | filing |
News
No headline names them, or the companies they trade most, lately.